FT
JAZZ icon

Fiduciary Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Fiduciary Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Sell
8,416
-125
-1% -$27.4K 0.02% 279
2026
Q1 		$1.61M Sell
8,541
-2,688
-24% -$470K 0.02% 320
2025
Q4 		$1.91M Sell
11,229
-1,185
-10% -$182K 0.02% 289
2025
Q3 		$1.64M Sell
12,414
-1,097
-8% -$132K 0.02% 318
2025
Q2 		$1.43M Sell
13,511
-29,934
-69% -$3.25M 0.02% 332
2025
Q1 		$5.39M Buy
43,445
+37,059
+580% +$4.83M 0.07% 158
2024
Q4 		$786K Sell
6,386
-384
-6% -$45.3K 0.01% 400
2024
Q3 		$754K Buy
6,770
+2,246
+50% +$246K 0.01% 408
2024
Q2 		$483K Buy
4,524
+1,481
+49% +$163K 0.01% 456
2024
Q1 		$366K Buy
+3,043
New +$373K 0.01% 520

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Fiduciary Trust's JAZZ Position: Q2 2026 in Review

Fiduciary Trust reduced its Jazz Pharmaceuticals (JAZZ) stake by 1.5% in Q2 2026, selling an estimated $27.4K and leaving 8,416 shares worth $2.03M. The position accounts for 0.02% of the portfolio, ranked #279.

Fiduciary Trust first reported a position in JAZZ in Q1 2024 and has held it in 10 quarters since. The position peaked at $5.39M in Q1 2025. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Fiduciary Trust held 8,416 shares of Jazz Pharmaceuticals worth $2.03M as of Q2 2026.
  • Fiduciary Trust sold 125 Jazz Pharmaceuticals shares in Q2 2026, an estimated $27.4K.
  • Jazz Pharmaceuticals made up 0.02% of Fiduciary Trust's portfolio in Q2 2026, its #279 holding.
  • Fiduciary Trust first reported a position in Jazz Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Fiduciary Trust's Jazz Pharmaceuticals position peaked at $5.39M in Q1 2025.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.